Prebiotics and resistance to gastrointestinal infections.

作者: G. R. Gibson , A. L. McCartney , R. A. Rastall

DOI: 10.1079/BJN20041343

关键词:

摘要: Acute gut disorder is a cause for significant medicinal and economic concern. Certain individual pathogens of the gut, often transmitted in food or water, have ability to severe discomfort. There need manage such conditions more effectively. The route reducing risk intestinal infections through diet remains largely unexplored. Antibiotics are effective at inhibiting pathogens; however, these should not be prescribed absence disease therefore cannot used prophylactically. Moreover, their indiscriminate use has reduced effectiveness. Evidence accumulated suggest that some health-promoting bacteria (probiotics) can elicit multiplicity inhibitory effects against pathogens. Hence, an increase numbers prove repressing pathogen colonisation if/when infectious agents enter gut. As such, fortification indigenous bifidobacteria/lactobacilli by using prebiotics improve protection. number potential mechanisms lactic acid reduce infections. Firstly, metabolic endproducts as acids excreted micro-organisms may lower pH levels below those which able effectively compete. Also, many lactobacilli bifidobacteria species excrete natural antibiotics, broad spectrum activity. Other include improved immune stimulation, competition nutrients blocking adhesion sites Many like type 1 fimbriated Escherichia coli, salmonellae campylobacters utilise oligosaccharide receptor Once established, they then gastroenteritis invasive and/or toxin forming properties. One extrapolation prebiotic concept simulate lumen. 'decoyed' into binding host mucosal interface. combined upon flora anti-adhesive strategies lead towards new dietary interventions safety agents.

参考文章(30)
T. Mizota, Functional and nutritional foods containing bifidogenic factors Bulletin. International Dairy Federation. ,(1996)
B. C. Tungland, J. L. Slavin, J. L. Causey, P. D. Meyer, The immune effects of inulin in vitro and in vivo Agro Food Industry Hi-tech. ,vol. 11, pp. 18- 20 ,(2000)
A. J. McBain, G. T. Macfarlane, Investigations of Bifidobacterial Ecology and Oligosaccharide Metabolism in a Three-Stage Compound Continuous Culture System. Scandinavian Journal of Gastroenterology. ,vol. 222, pp. 32- 40 ,(1997) , 10.1080/00365521.1997.11720715
Glenn Gibson, J.M. Saavedra, S. Macfarlane, G.T. Macfarlane, Gastrointestinal microbial disease Chapman and Hall. ,(1997)
Glenn Gibson, C.L. Willis, J. Van Loo, Non-digestible oligosaccharides and bifidobacteria - implications for health International Sugar Journal. ,vol. 96, pp. 381- 387 ,(1994)
R. Fuller, Probiotics 2 : applications and practical aspects Chapman & Hall Ltd. ,(1997)
R K Buddington, C H Williams, S C Chen, S A Witherly, Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. The American Journal of Clinical Nutrition. ,vol. 63, pp. 709- 716 ,(1996) , 10.1093/AJCN/63.5.709
B B Finlay, S Falkow, Common themes in microbial pathogenicity. Microbiological Research. ,vol. 53, pp. 210- 230 ,(1989) , 10.1128/MR.53.2.210-230.1989
Tomotari Mitsuoka, Bifidobacteria and their role in human health. Journal of Industrial Microbiology & Biotechnology. ,vol. 6, pp. 263- 267 ,(1990) , 10.1007/BF01575871